SEVERANCE AGREEMENTSeverance Agreement • March 29th, 2019 • Aileron Therapeutics Inc • Pharmaceutical preparations • Massachusetts
This SEVERANCE AGREEMENT (this “Agreement”) is made and entered into as of October 1, 2018 by and between Donald Dougherty (“Executive”) and Aileron Therapeutics, Inc. (the “Company”).
Consulting AgreementConsulting Agreement • March 29th, 2019 • Aileron Therapeutics Inc • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (the “Agreement”), made this 30th day of September, 2018, is entered into by Aileron Therapeutics, Inc., a Delaware corporation (the “Company”), and John P. Longenecker, an individual residing at 1436 Tres Hermanas Way, Encinitas, CA, 92024 (the “Consultant”).
